BACKGROUND Myocardial injury after transcatheter aortic valve replacement (TAVR) is common, but its cause and relationship to the extent of myocardial tissue loss remain unclear.
T ranscatheter aortic valve replacement (TAVR) has evolved into standard procedure for patients with aortic stenosis who are at high risk for conventional surgery (1) . The interventional approach has been shown to be more effective than standard medical treatment in high-risk patients, but it is nonetheless associated with relatively high mortality and morbidity (2) . Periprocedural myocardial injury has been identified as a predictor of unfavorable outcome after TAVR (3) , and various hypotheses exist concerning the underlying mechanisms of myocardial damage, including global myocardial ischemia due to extreme hypotension, direct trauma during balloon inflation or prosthesis placement, and coronary embolization of aortic valve debris (3, 4) . Hereof, an obstruction of the coronary ostia by the valve prosthesis or leaflets has to be distinguished (5) . However, the cause of myocardial injury in patients undergoing TAVR is not well-described, and the extent of myocardial tissue loss has not yet been investigated. For this purpose, cardiac magnetic resonance (CMR) imaging-being the gold standard for detection and quantification of myocardial infarction (MI)-may be considered the most appropriate method (6) . In the setting of percutaneous coronary intervention (PCI), a close association has been described between infarct size determined by CMR, left ventricular ejection fraction (LVEF), and biomarker release (7, 8) ; however, such data on TAVR are currently lacking.
The objectives of our study were to examine the prevalence and degree of new Implantations were performed as previously reported (1, 9) . In brief, for the transapical ( 
RESULTS
PATIENTS AND PROCEDURAL RESULTS. Eightyseven patients who met all of the inclusion criteria were enrolled, and a baseline CMR was acquired.
In 26 cases, post-procedural CMR was not available for several reasons: 12 patients required pacemaker implantation, 6 were in unstable condition, death occurred in 5 cases (emergency conversion in 3 patients, 1 case of major stroke, and 1 case of annular rupture), and 3 patients refused the post-procedural examination. Therefore, the study protocol was completed in 61 patients (TF: Sapien XT, n ¼ 18; Corevalve, n ¼ 17; TA: Sapien XT, n ¼ 26). Baseline characteristics were similar between the groups with TA and TF access ( Table 1) . None of the patients reported symptoms indicative of MI.
COMPARISON OF PATIENTS WITH NEW LE VERSUS
PATIENTS WITHOUT NEW LE. Except for reduced renal function in the group with new LE (LE þ ), there were no further significant differences in baseline and procedural parameters between the LE þ group and the group without new LE (LE -), including findings on electrocardiography ( Table 2 , Online Fig. 1 ).
C M R i m a g i n g . The time intervals of baseline CMR to procedure and from procedure to post-interventional scans were similar between the LE þ and LEgroups ( Table 2 ). Image quality overall was appropriate, and the implanted prostheses did not produce artefacts that would have interfered with any of the analyses performed.
The results of the CMR volumetric analyses are summarized in Table 2 . Baseline CMR revealed preexisting myocardial ischemic scars in 42 patients (68.8%), with an average mass of 10.9 g (IQR: 5.1 to 21.9 g) or 7.4% (IQR: 3.9 to 11.7 g) of total LV mass.
Among these patients, 9 of 42 (21.4%) had no relevant coronary artery disease, and 28 of 42 (66.7%) had no history of MI. There was no relevant difference in baseline infarct size between the LE þ and LEgroups ( Table 2) . New hyperenhancement after TAVR was observed in 11 patients (18%) featuring a primarily subendocardial or intramural localization ( Fig. 1 , Online Table 1 ). The mean mass of new LE was 3.7 g (IQR: 1.2 to 6 g), or 1.8% (IQR: 1.3 to 4.1 g) of total LV mass. The transmural extents ranged from 25% to <50% in 2 patients, 50% to <75% in 4 patients, and 75% to 100% in There were no significant differences with respect to infarct size, change in EF, and increase in biomarker levels between the group with a viable endocardial rim and that without (Online Table 2 ).
Prior PCI/MI with known coronary artery disease was present in 5 cases. Four patients had coronary stenosis of >50% before TAVR, without the need for Neither baseline values nor post-operative maximum concentrations of hs-cTnT and CK-MB were significantly different between the LE þ and LEgroups ( Table 2) .
The results of the subgroup analysis according to the chosen access are depicted in Figures 3 and 4 . A threshold of 209 ng/l yielded a sensitivity of 71.4% and a specificity of 78.8% (Fig. 5) . The area under the curve for a relative increase in the concentration of (11) . This suggested mechanism corresponds well to the previously described finding that cerebral embolism occurs in up to 84% of patients after TAVR (12) .
CMR is acknowledged to be the most appropriate method for the detection and quantification of infarct size (6) . Its value has been described for the imaging of periprocedural myocardial necrosis after PCI (7, 8) . Ricciardi Within both the femoral and apical subgroups, hs-cTnT concentrations were higher in the LE þ patients, but the difference was significant only within the transfemoral group (p ¼ 0.03).
Abbreviations as in Figure 1 . CARDIAC BIOMARKERS. A post-procedural elevation of cardiac biomarker levels was observed in all patients, indicating that myocardial damage commonly occurs to varying degrees. We further noted a lack of correlation between the level of cardiac biomarkers and the mass of new myocardial hyperenhancement detected by CMR; this is in contrast to the setting of PCI, in which such an association has been described to be common (7, 8 The inverse relationship between reduced renal function and higher troponin levels is well-known, and we cannot fully exclude that increased troponin concentrations in the LE þ group may be ascribed to some extent to the differences in renal function. Nonetheless, despite lower GFR in LE þ patients, biomarker levels at baseline were similar between these 2 groups, so at the least, the initial conditions were comparable.
We assume that the TAVR procedure is associated with multiple confounding factors that contribute to myocardial damage. Elevated cardiac biomarkers certainly indicate myocardial injury, but an explicit attribution to a definite cause is difficult. in half of those patients (19) . However, global LV function has been shown to be unaffected by these localized and often transient wall-motion abnormalities and seems to rather improve over time (20) .
Therefore, we presume that the impact of the apical approach on global LV function can be neglected. This table summarizes various mechanisms of myocardial damage and their clinical implications in selected cardiac interventions. The described patterns may be subdivided into classic myocardial infarction (types 2 and 4) and miscellaneous forms including procedurerelated injury (e.g., apical access, trans-septal puncture) or mechanical irritation (e.g., balloon valvuloplasty, catheter manipulation). Notably, coronary embolism is a complication that is common to many interventional procedures. PCI ¼ percutaneous coronary intervention; TAVR ¼ transcatheter aortic valve replacement. 
